![Daniel Deardorf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Daniel Deardorf is currently Chief Executive Officer & Director at Glycologix, Inc. Formerly, Mr. Deardorf was Senior Vice President-Commercial at Flexion Therapeutics, Inc.
Daniel Deardorf active positions
| Companies | Position | Start |
|---|---|---|
Glycologix, Inc.
 Glycologix, Inc. BiotechnologyHealth Technology Operates as an innovative clinical-stage biotechnology company that develops locally delivered biopolymers aimed at the protection and repair of soft tissues | Chief Executive Officer | 01/01/2021 |
Former positions of Daniel Deardorf
| Companies | Position | End |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Glycologix, Inc.
Glycologix, Inc. BiotechnologyHealth Technology Operates as an innovative clinical-stage biotechnology company that develops locally delivered biopolymers aimed at the protection and repair of soft tissues | Health Technology |
- Stock Market
- Insiders
- Daniel Deardorf
